Andrew M. Oh serves as Executive at Rubius Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew M. Oh has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 5, 2024 involved receiving (via award) 4,000 shares valued at $0.
Andrew M. Oh currently holds 16,000 shares of Rubius Therapeutics, Inc. (RUBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew M. Oh has been a net neutral trader of RUBY stock. They have purchased $0 and sold $0 worth of shares.
Andrew M. Oh's most recent insider trade was on Jun 5, 2024, when they sold 4,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 16, 2022 | SYRS | $0 | Award | 8,000 | $N/A | Discretionary |
| May 15, 2020 | RUBY | $23.7K | Option Exercise | 5,000 | $4.74 | Discretionary |